본문 바로가기

Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q3
저널
PEDIATRICS INTERNATIONAL61(7) · pp.688 · 2019
피인용
Web of Science 16Scopus 20
FWCI (Scopus)
0.46
JCR IF
JCR 2018 0.939
ISSN
1328-8067

저자

  1. Kang, Ji-Man제1저자Department of Pediatrics, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea
  2. Lee, JinaDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  3. Kim, Yun-KyungDepartment of Pediatrics, Korea University Ansan Hospital, Ansan, Korea
  4. Cho, Hye KyungDepartment of Pediatrics, Gachon University School of Medicine, Incheon, Korea
  5. 박수은Department of Pediatrics, Pusan National University Children's Hospital, Yangsan, Korea
  6. Kim, Kyung-HyoDepartment of Pediatrics, Ewha Women's University School of Medicine, Seoul, Korea
  7. Kim, Min-JiStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea
  8. Kim, SeonwooStatistics and Data Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea
  9. Kim, Yae-Jean교신저자Department of Pediatrics, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea

초록

Background: We investigated the characteristics and clinical outcomes of respiratory syncytial virus (RSV)-related pediatric intensive care unit (PICU) hospitalization and assessed the palivizumab (PZ) prophylaxis eligibility according to different guidelines from Korea, EU, and USA. Methods: In this multicenter study, children <18 years of age hospitalized in six PICU from different hospitals due to severe RSV infection between September 2008 and March 2013 were included. A retrospective chart review was performed. Results: A total of 92 patients were identified. The median length of PICU stay was 6 days (range, 1–154 days) and median PICU care cost was USD2,741 (range, USD556–98 243). Of 62 patients who were <2 years old at the beginning of the RSV season, 33 (53.2%) were high-risk patients for severe RSV infection. Hemodynamically significant congenital heart disease (22.6%) was the most common risk factor, followed by chronic lung disease (11.3%), neuromuscular disease or congenital abnormality of the airway (NMD/CAA) (11.3%), and prematurity (8.1%). The percentage of patients eligible for PZ prophylaxis ranged from 38.7% to 48.4% based on the guidelines, but only two (2.2%) received PZ ≤30 days prior to PICU admission. The median duration of mechanical ventilation was longer in children with NDM/CAA than in those without risk factors (26 days; range, 24–139 days vs 6 days, range, 2–68 days, P = 0.033). RSV-attributable mortality was 5.4%. Conclusions: Children <2 years old with already well-known high risks represent a significant proportion of RSV-related PICU admissions. Increasing of the compliance for PZ prophylaxis practice among physicians is needed. Further studies are needed to investigate the burden of RSV infection in patients hospitalized in PICU, including children with NMD/CAA.

키워드

eligibilityguidelineneuromuscular disorder or congenital abnormality of the airwaypediatric intensive care unitrespiratory syncytial virus

식별자

Scopus EID
2-s2.0-85069901507
WoS UID
000478749000010